Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:AET
CUSIP00817Y10
Phone860-273-0123
Debt
Debt-to-Equity Ratio0.44
Current Ratio0.74
Quick Ratio0.74
Price-To-Earnings
Trailing P/E Ratio20.72
Forward P/E Ratio18.06
P/E Growth1.76
Sales & Book Value
Annual Sales$60.54 billion
Price / Sales1.10
Cash Flow$12.3575 per share
Price / Cash16.53
Book Value$48.46 per share
Price / Book4.22
Profitability
EPS (Most Recent Fiscal Year)$9.86
Net Income$1.90 billion
Net Margins5.77%
Return on Equity20.66%
Return on Assets5.93%
Miscellaneous
Employees47,950
Outstanding Shares327,400,000
Market Cap$67.34 billion
Aetna (NYSE:AET) Frequently Asked Questions
What is Aetna's stock symbol?
Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."
How often does Aetna pay dividends? What is the dividend yield for Aetna?
Aetna declared a quarterly dividend on Friday, May 18th. Stockholders of record on Wednesday, July 25th will be given a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date of this dividend is Tuesday, July 24th. View Aetna's Dividend History.
How will Aetna's stock buyback program work?
Aetna declared that its board has authorized a stock repurchase program on Friday, April 7th 2017, which authorizes the company to repurchase $4,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 98% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its shares are undervalued.
How were Aetna's earnings last quarter?
Aetna Inc (NYSE:AET) released its quarterly earnings results on Thursday, August, 2nd. The company reported $3.43 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $3.04 by $0.39. The business earned $15.56 billion during the quarter, compared to analyst estimates of $15.59 billion. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The firm's quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.42 earnings per share. View Aetna's Earnings History.
When is Aetna's next earnings date?
What price target have analysts set for AET?
12 analysts have issued 12-month target prices for Aetna's stock. Their predictions range from $179.00 to $212.00. On average, they anticipate Aetna's share price to reach $201.75 in the next twelve months. This suggests that the stock has a possible downside of 1.2%. View Analyst Price Targets for Aetna.
What is the consensus analysts' recommendation for Aetna?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aetna in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Aetna.
What are Wall Street analysts saying about Aetna stock?
Here are some recent quotes from research analysts about Aetna stock:
- 1. Cantor Fitzgerald analysts commented, ". We are downgrading the shares of from Overweight. AET shares now trade at just a 4.6% discount to the implied CVS Health (CVS – Not Covered) acquisition value of about $207 and 2.1% below our fundamental-based price target of $202. Indeed, the spread has narrowed as the likelihood of regulatory approval has increased. In early May, the shares traded at a 13% discount to the CVS acquisition value and our fundamental-based price target of $202. AET/CVS is a vertical merger, which is inherently difficult to challenge, but there remains some potential overlap in the Medicare Part D area." (8/22/2018)
- 2. According to Zacks Investment Research, "Aetna’s second-quarter 2018 earnings of $3.43 per share beat the Zacks Consensus Estimate by 11.7%. The company had reported earnings of $3.42 in the year-ago quarter. The earnings beat was mainly achieved on the back of a lower tax rate, which was partly offset by an increase in expenses. Aetna's shares have outperformed the industry in a year’s time. Also, the company has witnessed its estimates for the current year move upward over the last seven days. It gains largely from its growing Government business. The recent sale of its U.S. Group Life and Disability business will enable the company to focus on its core growth areas. The company is on track to be acquired by CVS Health. However, its revenues remain under pressure. Its membership has been declining and rising expenses continue to hurt." (8/6/2018)
Who are some of Aetna's key competitors?
Who are Aetna's key executives?
Aetna's management team includes the folowing people:
- Mr. Mark Thomas Bertolini, Chairman & CEO (Age 61)
- Ms. Karen Sue Lynch, Pres (Age 55)
- Mr. Shawn Michael Guertin, Exec. VP, CFO & Chief Enterprise Risk Officer (Age 54)
- Mr. Richard Michael Jelinek, Exec. VP and Head of Enterprise Strategy & Integration (Age 52)
- Ms. Margaret M. McCarthy, Exec. VP of Operations & Technology (Age 64)
Has Aetna been receiving favorable news coverage?
Media stories about AET stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Aetna earned a media and rumor sentiment score of 0.18 on Accern's scale. They also assigned news articles about the company an impact score of 46.57 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Aetna.
Who are Aetna's major shareholders?
Aetna's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.12%), FMR LLC (2.36%), Northern Trust Corp (1.16%), Dimensional Fund Advisors LP (1.12%), Janus Henderson Group PLC (1.01%) and OppenheimerFunds Inc. (0.88%). Company insiders that own Aetna stock include Francis S Soistman Jr, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Institutional Ownership Trends for Aetna.
Which major investors are selling Aetna stock?
AET stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Arrowgrass Capital Partners US LP, Renaissance Technologies LLC, LSV Asset Management, PNC Financial Services Group Inc., Janus Henderson Group PLC, United Services Automobile Association and Canada Pension Plan Investment Board. View Insider Buying and Selling for Aetna.
Which major investors are buying Aetna stock?
AET stock was bought by a variety of institutional investors in the last quarter, including PointState Capital LP, Natixis, Robeco Institutional Asset Management B.V., Naya Capital Management UK Ltd., Cornerstone Wealth Management LLC, FMR LLC, Bank of Nova Scotia and Abrams Capital Management L.P.. View Insider Buying and Selling for Aetna.
How do I buy shares of Aetna?
Shares of AET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aetna's stock price today?
One share of AET stock can currently be purchased for approximately $204.27.
How big of a company is Aetna?
Aetna has a market capitalization of $67.34 billion and generates $60.54 billion in revenue each year. The company earns $1.90 billion in net income (profit) each year or $9.86 on an earnings per share basis. Aetna employs 47,950 workers across the globe.
How can I contact Aetna?
Aetna's mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company can be reached via phone at 860-273-0123 or via email at [email protected]
MarketBeat Community Rating for Aetna (NYSE AET)
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe AET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AET will underperform the S&P 500 over the long term. You may vote once every thirty days.
